References
- Kim K, Li B, Winer J, Armanini M, Gillett N, Phillips H, Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993; 362: 841–844, [INFOTRIEVE], [CSA]
- Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13(1)18–32, [INFOTRIEVE], [CSA], [CROSSREF]
- Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161(2)851–858, [INFOTRIEVE], [CSA], [CROSSREF]
- Plouet J, Schilling J, Gospodarowicz D. Isolation and characterization of a newly identified cell mitogen produced by AtT-20 cells. EMBO J 1989; 8(12)3801–3806, [INFOTRIEVE], [CSA]
- Conn G, Bayne ML, Soderman DD, Kwok PW, Sullivan KA, Palisi TM, Hope DA, Thomas KA. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 1990; 87(7)2628–2632, [INFOTRIEVE], [CSA], [CROSSREF]
- Zachary I. Vascular endothelial growth factor. Int J Biochem Cell B 1998; 30: 1169–1174, [CSA], [CROSSREF]
- Ku DD, Zaleski JK, Liu S, Brock T. Vascular endothelial growth factor induces EDRF-dependent relaxation of coronary arteries. Am J Physiol 1993; 265: H586–H592, [INFOTRIEVE], [CSA]
- Yang R, Thomas GR, Bunting S. Effects of VEGF on hemodynamics and cardiac performance. J Cardiovasc Pharmacol 1996; 27: 838–844, [INFOTRIEVE], [CSA], [CROSSREF]
- Vallance P, Chan N. Endothelial function and nitric oxide: clinical relevance. Heart 2001; 85: 342–350, [INFOTRIEVE], [CSA], [CROSSREF]
- Lowenstein CJ, Dimerman JL, Snyder SH. Nitric oxide: A physiological messenger. Ann Intern Med 1994; 120: 227–237, [INFOTRIEVE], [CSA]
- Magazine HI. Detection of endothelial cell-derived nitric oxide: current trends and future directions. Adv Neuroimmunol 1995; 5: 479–490, [INFOTRIEVE], [CSA], [CROSSREF]
- Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997; 100: 3131–3139, [INFOTRIEVE], [CSA]
- Hood JD, Meininger CJ, Ziche M, Granger HJ. VEGF upregulates eNOS message, protein, and NO production in human endothelial cells. Am J Physiol Heart Circ Phy 1998; 43: H1054–H1058, [CSA]
- Bouloumié A, Schini-Kerth V, Busse R. Vascular endothelial growth factor up-regulates nitric oxide synthase in endothelial cells. Cardiovasc Res 1999; 41(3)773–780, [CSA], [CROSSREF]
- Matsunaga T, Warltier D, Weihraush D, Moniz M, Tessmer J, Chilian W. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 2000; 102: 3098–3103, [INFOTRIEVE], [CSA]
- Ziche M, Morbidelli L, Choudhuri R, Zhang H, Donnini S, Granger H, Bicknell R. Nitric oxide-synthase lies downstream of vascular endothelial growth factor but not basic fibroblast growth factor induced angiogenesis. J Clin Invest 1997; 99: 2625–2634, [INFOTRIEVE], [CSA]
- Morbidelli L, Chang C, Douglas JG, Granger HJ, Ledda F, Ziche M. Nitric oxide mediates the mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996; 270(39)H411–H415, [INFOTRIEVE], [CSA]
- Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes J, Fishman M, Huang P, Isner J. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998; 101: 2567–2578, [INFOTRIEVE], [CSA]
- Theodoridou S, Vyzantiadis T, Vakalopoulou S, Perifanis V, Tziomalos K, Vyzantiadis A, Garipidou V. Elevated levels of serum vascular endothelial growth factor in patients with polycythaemia vera. Acta Haematol 2003; 110(1)16–19, [INFOTRIEVE], [CSA], [CROSSREF]
- Webb NJ, Bottomley MJ, Watson CJ, Brenchley PE. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurements of circulating VEGF levels in clinical disease. Clin Sci. (Colch) 1998; 94: 395–404, [CSA]
- Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C, Selby PJ. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 1998; 77: 956–964, [INFOTRIEVE], [CSA]
- Graham E, Adatia I, Yazdanpanah M, Makela S. Nitrite and nitrate analyses: a clinical biochemistry perspective. Clin Biochem 1998; 31(4)195–220, [CSA], [CROSSREF]
- Westfelt UN, Benthin G, Lundin S, Stenqvist O, Wennmalm A. Conversion of inhaled nitric oxide to nitrate in man. Br J Pharmacol 1995; 114: 1621–1624, [INFOTRIEVE], [CSA]
- Viinikka L. Nitric oxide as a challenge for the clinical chemistry laboratory. Scand J Clin Lab Invest 1996; 56: 577–581, [INFOTRIEVE], [CSA]
- Arroyo M, Caramelo C, Castilla M, Pacheco F, Martin O, Arias J. Role of vascular endothelial growth factor in the response to vessel injury. Kidney Int 1998; 54(Suppl. 68)S7–S9, [CSA], [CROSSREF]
- Williams B, Baker AQ, Gallacher B, Lodwick D. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 1995; 25: 913–917, [INFOTRIEVE], [CSA]
- Namiki A, Brogi E, Kearney M, Kim EA, Wu T, Couffinhal T, Varticovski L, Isner JM. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 1995; 270: 31189–31195, [INFOTRIEVE], [CSA], [CROSSREF]
- Belgore FM, Blann AD, Li-Saw-Hee FL, Beevers DG, Lip GYH. Plasma levels of vascular endothelial growth factor and its soluble receptor (sFlt-1) in essential hypertension. Am J Cardiology 2001; 87: 805–807, [CSA], [CROSSREF]
- Coller BS. Platelets in cardiovascular thrombosis and thrombolysis. The Heart and Cardiovascular System: Scientific Foundations 2nd. Raven, New York 1991; 1: 219–273
- Nagy JA, Brown LF, Senger DR, Lanir N, Van de Water L, Dvorak AM, Dvorak HF. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 1988; 948: 305–326, [CSA]
- Ziche M, Morbidelli L. Nitric oxide and angiogenesis. J Neuro-Oncol 2000; 50: 139–148, [CSA], [CROSSREF]
- Boulanger C. Secondary endothelial dysfunction: hypertension and heart failure. J Mol Cell Cardiol 1999; 31(1)39–49, [INFOTRIEVE], [CSA], [CROSSREF]
- Qiu C, Muchant D, Beierwaltes W, Racusen L, Baylis C. Evolution of chronic nitric oxide inhibition hypertension. Relationship to renal failure. Hypertension 1998; 31(part 1)21–26, [INFOTRIEVE], [CSA]
- Forte P, Copland M, Smith L, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet 1997; 349: 837–842, [INFOTRIEVE], [CSA], [CROSSREF]
- Shoji M, Tsutaya S, Saito R, Takamatu H, Yasujima M. Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in Northern Japan. Life Sci 2000; 66(26)2557–2562, [INFOTRIEVE], [CSA], [CROSSREF]
- Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, Kamitani S, Harada M, Ishikawa M, Kuwahara K, Ogawa E, Hamanaka I, Takahashi N, Kaneshige T, Teraoaka H, Akamizu T, Azuma N, Yoshimasa Y, Yoshimasa T, Itoh H, Masuda I, Yasue H, Nakao K. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998; 32: 3–8, [INFOTRIEVE], [CSA]
- Huang PL, Huang Z, Mashino H, Block KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377: 239–242, [INFOTRIEVE], [CSA], [CROSSREF]